{
    "prefix": "Approach the following multiple choice question the way a medical researcher would. ",
    "problem_prompt": "Approach the following multiple choice question the way a medical researcher would. Which of the following drugs used to treat type II diabetes mellitus causes weight loss:\n1: Metformin\n2: Glimepiride\n3: Repaglinide\n4: Gliclazide",
    "solution": 1,
    "gpt_response": "To determine which drug used to treat type II diabetes mellitus causes weight loss, a medical researcher would conduct a systematic review of scientific studies investigating the effects of each drug on weight in patients with diabetes. They would look for randomized controlled trials and observational studies that specifically examined weight changes as an outcome of treatment with each drug.\n\nIn this case, based on the available evidence, Metformin is the drug that is most commonly associated with weight loss in patients with type II diabetes mellitus. Metformin works by reducing hepatic glucose production and improving insulin sensitivity, leading to decreased blood glucose levels and potential weight loss in some patients. Glimepiride, Repaglinide, and Gliclazide, on the other hand, are sulfonylurea medications commonly associated with weight gain due to their mechanisms of action that stimulate insulin secretion.",
    "solution_prompt": "The following is a response to a question, with options 1, 2, 3, 4. Yes or no, is the final solution obtained in the following response 1?: To determine which drug used to treat type II diabetes mellitus causes weight loss, a medical researcher would conduct a systematic review of scientific studies investigating the effects of each drug on weight in patients with diabetes. They would look for randomized controlled trials and observational studies that specifically examined weight changes as an outcome of treatment with each drug.\n\nIn this case, based on the available evidence, Metformin is the drug that is most commonly associated with weight loss in patients with type II diabetes mellitus. Metformin works by reducing hepatic glucose production and improving insulin sensitivity, leading to decreased blood glucose levels and potential weight loss in some patients. Glimepiride, Repaglinide, and Gliclazide, on the other hand, are sulfonylurea medications commonly associated with weight gain due to their mechanisms of action that stimulate insulin secretion.",
    "gpt_response_correct_incorrect": "Yes. The final solution obtained in the response is option 1: Metformin is the drug that is most commonly associated with weight loss in patients with type II diabetes mellitus.",
    "attempts": 1,
    "yes_no": "yes",
    "gpt_response_difficulty": "1",
    "difficulty_value": "1"
}